BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5051750)

  • 1. Defective decarboxylase in branched chain ketoacid oxidase multienzyme complex in classic type of maple syrup urine disease.
    RĂ¼diger HW; Langenbeck U; Schulze-Schencking M; Goedde HW
    Humangenetik; 1972; 14(4):257-63. PubMed ID: 5051750
    [No Abstract]   [Full Text] [Related]  

  • 2. Maple syrup urine disease: analysis of branched chain ketoacid decarboxylation in cultured fibroblasts.
    Wendel U; Wentrup H; RĂ¼diger HW
    Pediatr Res; 1975 Sep; 9(9):709-17. PubMed ID: 1202420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The enzyme defect in maple syrup urine disease (branched chain ketoaciduria).
    Seegmiller JE; Westall RG
    J Ment Defic Res; 1967 Dec; 11(4):288-94. PubMed ID: 5582930
    [No Abstract]   [Full Text] [Related]  

  • 4. Heterogeneity in maple syrup urine disease: aspects of cofactor requirement and complementation in cultured fibroblasts.
    Singh S; Willers I; Goedde HW
    Clin Genet; 1977 Apr; 11(4):277-84. PubMed ID: 192504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new variant of maple syrup urine disease (branched chain ketoaciduria). Clinical and biochemical evaluation.
    Schulman JD; Lustberg TJ; Kennedy JL; Museles M; Seegmiller JE
    Am J Med; 1970 Jul; 49(1):118-24. PubMed ID: 5431474
    [No Abstract]   [Full Text] [Related]  

  • 6. Branched chain alpha-keto acid metabolism. I. Isolation, purification, and partial characterization of bovine liver alpha-ketoisocaproic:alpha-keto-beta-methylvaleric acid dehydrogenase.
    Connelly JL; Danner DJ; Bowden JA
    J Biol Chem; 1968 Mar; 243(6):1198-203. PubMed ID: 5689906
    [No Abstract]   [Full Text] [Related]  

  • 7. Maple syrup urine disease: branched-chain keto acid decarboxylation in fibroblasts as measured with amino acids and keto acids.
    Dancis J; Hutzler J; Cox RP
    Am J Hum Genet; 1977 May; 29(3):272-9. PubMed ID: 868873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme activity in classical and variant forms of maple syrup urine disease.
    Dancis J; Hutzler J; Snyderman SE; Cox RP
    J Pediatr; 1972 Aug; 81(2):312-20. PubMed ID: 5042489
    [No Abstract]   [Full Text] [Related]  

  • 9. The relationship between the branched chain amino acids and their alpha-ketoacids in maple syrup urine disease.
    Snyderman SE; Goldstein F; Sansaricq C; Norton PM
    Pediatr Res; 1984 Sep; 18(9):851-3. PubMed ID: 6483508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro response of human branched chain alpha-ketoacid dehydrogenase to thiamine and thiamine pyrophosphate.
    Danner DJ; Wheeler FB; Lemmon SK; Elsas LJ
    Pediatr Res; 1978 Mar; 12(3):235-8. PubMed ID: 643394
    [No Abstract]   [Full Text] [Related]  

  • 11. Intermittent branched chain ketonuria (variant of maple syrup urine disease).
    Irwin WC; Martel SB; Goluboff N
    Clin Biochem; 1971 Jun; 4(2):52-8. PubMed ID: 5128296
    [No Abstract]   [Full Text] [Related]  

  • 12. A new variety of maple syrup urine disease.
    Harkness RA; Cockburn F; Grant M; Giles MM; Turner TL; Darling JA
    Ann Clin Biochem; 1977 May; 14(3):146-8. PubMed ID: 869494
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular characterization of maple syrup urine disease patients from Tunisia.
    Jaafar N; Moleirinho A; Kerkeni E; Monastiri K; Seboui H; Amorim A; Prata MJ; Quental S
    Gene; 2013 Mar; 517(1):116-9. PubMed ID: 23313820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of branched chain acyl-transferase as a cause of maple syrup urine disease.
    Danner DJ; Armstrong N; Heffelfinger SC; Sewell ET; Priest JH; Elsas LJ
    J Clin Invest; 1985 Mar; 75(3):858-60. PubMed ID: 3980729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition by the branched-chain 2-oxo acids of the 2-oxoglutarate dehydrogenase complex in developing rat and human brain.
    Patel MS
    Biochem J; 1974 Oct; 144(1):91-7. PubMed ID: 4462577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiamin-responsive maple-syrup-urine disease: decreased affinity of the mutant branched-chain alpha-keto acid dehydrogenase for alpha-ketoisovalerate and thiamin pyrophosphate.
    Chuang DT; Ku LS; Cox RP
    Proc Natl Acad Sci U S A; 1982 May; 79(10):3300-4. PubMed ID: 6954481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A distinct variant of intermediate maple syrup urine disease.
    Gonzalez-Rios MC; Chuang DT; Cox RP; Schmidt K; Knopf K; Packman S
    Clin Genet; 1985 Feb; 27(2):153-9. PubMed ID: 3978850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Family with intermittent maple syrup urine disease.
    Valman HB; Patrick AD; Seakins JW; Platt JW; Gompertz D
    Arch Dis Child; 1973 Mar; 48(3):225-8. PubMed ID: 4693464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiamine response in maple syrup urine disease.
    Fernhoff PM; Lubitz D; Danner DJ; Dembure PP; Schwartz HP; Hillman R; Bier DM; Elsas LJ
    Pediatr Res; 1985 Oct; 19(10):1011-6. PubMed ID: 3903643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of branched-chain alpha-ketoacid dehydrogenase complex by alpha-chloroisocaproate in normal and enzyme-deficient fibroblasts.
    Toshima K; Kuroda Y; Yokota I; Naito E; Ito M; Watanabe T; Takeda E; Miyao M
    Clin Chim Acta; 1985 Apr; 147(2):103-8. PubMed ID: 3987057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.